Andtbacka RH, Ross M, Agarwala SS, et al. A phase II multicentre trial of HF10, oncolytic virus immunotherapy, and ipilimumab combination treatment in patients with stage IIIB-IV unresectable or metastatic melanoma. SMR 2017, abstract SMR04-2.
7 Veni-beurzen voor MDL-onderzoek
aug 2024 | Hepatologie, IBD, Immuuntherapie, Maag-darm-leveroncologie, Pancreatitis, Parasitaire infecties